How can you treat cervical cancer? Learn the benchmarks of prevention, standard treatments and follow-up care that doctors recommend during this condition.
Washington, Sept 25 : Giving radiotherapy between or during chemotherapy cycles to women with early breast cancer could significantly reduce the risk of the cancer recurring in the breast or chest wall, a new study led by an Indian-origin researcher has s
Scientists at the Walter and Eliza Hall Institute have identified a way that chemotherapy causes platelet numbers to drop, answering in the process a decade-old question about the formation of platelets, tiny cells that allow blood to clot.
A major UK trial has produced firm evidence that giving radiotherapy between or during chemotherapy cycles to women with early breast cancer significantly reduces the risk of the cancer recurring in the breast or chest wall. The treatment, known as synchr
( Johns Hopkins Medical Institutions ) Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.
Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends. The chemotherapy side effect, described